SCP
TMO icon

Stevens Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Stevens Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$725K Buy
1,445
+56
+4% +$26.9K 0.14% 83
2026
Q1 		$683K Sell
1,389
-57
-4% -$30.9K 0.16% 74
2025
Q4 		$838K Buy
1,446
+85
+6% +$48.1K 0.22% 60
2025
Q3 		$660K Buy
+1,361
New +$633K 0.2% 61

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Stevens Capital Partners's TMO Position: Q2 2026 in Review

Stevens Capital Partners increased its Thermo Fisher Scientific (TMO) stake by 4% in Q2 2026, buying an estimated $26.9K and bringing the position to 1,445 shares worth $725K. The position accounts for 0.14% of the portfolio, ranked #83.

Stevens Capital Partners first reported a position in TMO in Q3 2025 and has held it in 4 quarters since. The position peaked at $838K in Q4 2025. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Stevens Capital Partners held 1,445 shares of Thermo Fisher Scientific worth $725K as of Q2 2026.
  • Stevens Capital Partners bought 56 Thermo Fisher Scientific shares in Q2 2026, an estimated $26.9K.
  • Thermo Fisher Scientific made up 0.14% of Stevens Capital Partners's portfolio in Q2 2026, its #83 holding.
  • Stevens Capital Partners first reported a position in Thermo Fisher Scientific in Q3 2025 and has held it in 4 quarters since.
  • Stevens Capital Partners's Thermo Fisher Scientific position peaked at $838K in Q4 2025.
  • 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Stevens Capital Partners's 13F filing for Q2 2026, filed 10 Aug 2026.